1 |
보건복지부 중앙암등록본부, 2009년 국가암등록통계, 2011 (http://www.cancer.go.kr)
|
2 |
통계청, 2013년 사망원인통계 결과, 2014 (http://www.kostat.go.kr)
|
3 |
Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 83(4):777-82, 1998
DOI
|
4 |
Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E, Use of complementary and alternative medicine in cancer patients: a Europnean survey, Ann Oncol. 16:655-663, 2005
DOI
|
5 |
Cragg GM, Newman DJ, Plants as a source of a anti-cancer agents, J Ethnopharmacol. 100:72-79, 2005
DOI
|
6 |
Vickers AJ, Kuo J, Cassileth BR. Unconventional anticancer agents: a systematic review of clinical trials. J Clin Oncol. 24(1):136-40, 2006
DOI
|
7 |
Vickers AJ, How to design a phase I trial of an anticancer botanical, J Soc integr Oncol. 4(1):46-51, 2006
|
8 |
Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RY, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, Kurzrock R, Pilot Study of Huachansu in Patients With Hepatocellular Carcinoma, Non small-Cell Lung Cancer, or Pancreatic Cancer, Cancer. 115:5309-5318, 2009
DOI
|
9 |
Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL, A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer, Breast Cancer Res Treat. 120:111-118, 2010
DOI
|
10 |
Deng G, Lin H, Seidman A, Fornier M, Andrea G, Wesa K, Yeung S, Cunningham-Rundles S, Vickers AJ, Cassileth B, A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects, J Cancer Res Clin Oncol. 135:1215-1221, 2009
DOI
|
11 |
McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK, Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 12:454-62, 2004
DOI
|
12 |
Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A, Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 94:1247-1249, 2002
DOI
|
13 |
Cassileth BR, Rizvi N, Deng G, Yeung KS, Vickers A, Guillen S, Woo D, Coleton M, Kris MG, Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients, Cancer Chemother Pharmacol. 65:67-71, 2009
DOI
|
14 |
Vickers AJ, Phase II designs for anticancer botanicals and supplements, J Soc Integr Oncol. 7(1):35-40, 2009
|
15 |
Saif MW, Li J, Lamb L, Kaley K, Elligers K, Jiang Z, Bussom S, Liu SH, Cheng YC, First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer, Cancer Chemother Pharmacol. 73:373-380, 2014
DOI
|
16 |
Cheung NK, Modak S, Vickers A, Knuckles B. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother. 51(10):557-564, 2002
DOI
|
17 |
Meng Z, Garrett CR, Shen Y, Liu L, Yang P, Huo Y, Zhao Q, Spelman AR, Ng CS, Chang DZ, Cohen L, Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas, Br J Cancer. 107:411-416, 2012
DOI
|
18 |
Attia A, Rapp SR, Case LD, D'Agostino R, Lesser G, Naughton M, McMullen K, Rosdhal R, Shaw EG, Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood, J Neurooncol. 109:357-363, 2012
DOI
|
19 |
Vickers AJ, Which botanicals or other unconventional anticancer agents should we take to clinical trial? J Soc Integr Oncol. 5(3):125-129, 2007
DOI
|
20 |
Vickers AJ, How to design a phase I trial of an anticancer botanical, J Soc Integr Oncol. 4(1):46-51, 2006
|
21 |
Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res. 1;62(9):2474-2477, 2002
|